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ATP-Induced Killing of Mycobacteria
by Human Macrophages Is Mediated
by Purinergic P2Z(P2X7) Receptors
D. A. Lammas,* C. Stober,* C. J. Harvey,² immunity also requires mycobacterial antigen-specific
N. Kendrick,² S. Panchalingam,* CD41, CD81, and TCR1 gd T cells (Orme, 1996). Within
and D. S. Kumararatne*³ mycobacterial granulomata, current dogma suggests
*Department of Immunology that T cell±derived cytokines like IFNg and TNF stimulate
²Department of Infection macrophages to kill or control the growth of intracellular
The Medical School, bacteria. However, single or multiple cytokines, when
University of Birmingham, added to human macrophages in vitro, do not reproduc-
Birmingham B15 2TT ibly inhibit intracellular mycobacterial growth, even when
UK these cells are so activated to kill other intracellular
³Department of Immunology parasites (Barnes and Molin, 1996).
City Hospital Histologically, immunocompetent human hosts usu-
NHS Trust ally develop paucibacillary granulomata characterized
Birmingham B18 7QH by a central zone of developing caseous ªnecrosisº con-
UK taining dying macrophages, surrounded by a cuff of
macrophages undergoing ªapoptosisº with activated
lymphocytes in close association. In addition, within the
Summary same tissue, infected hosts can also display resolving
or ªepitheloidº-type granulomata consisting of activated
The death of BCG-infected human macrophages in- macrophages, often with a central core of apoptotic
duced in vitro by ligation of surface CD95 (Fas), CD69, cells (S. P. and D. A. L., manuscript in preparation). In
or complement-mediated lysiswas shown not to result contrast, in immunodeficient subjects, granuloma for-
in the death of intracellular mycobacteria, whereas mation is poor, with minimal tissue necrosis and no
exposure to extracellular ATP initiated both macro- demonstrable macrophage apoptosis and the lesions
phage death and killed the intracellular bacteria. ATP are characteristically multibacillary (cf. lepromatous lep-
acted via P2Z receptors because these effects were rosy [Dannenberg and Rook, 1994]). Such studies sug-
mimicked by benzoylbenzoic ATP (a known agonist of gest that in vivo, death of infected macrophages by
P2Z receptors) and blocked by oxidized ATP, DIDS, apoptosis and/or necrosis may be associated with a
suramin, amiloride, and KN62 (known inhibitors of P2Z- protective host immune response against mycobacterial
mediated responses). ATP-mediated bacterial killing infection.
was independent of reactive nitrogen and oxygen in- In this study, various stimuli previously reported to
termediates and of actinomycin D or cycloheximide induce macrophage cell death in vitro, including com-
inhibition. ATP-induced macrophage cell death, BCG
plement-mediated lysis (Laochumroonvorapong et al.,
killing, and lucifer yellow dye incorporation were mini-
1996), ligation of surface CD95 (Fas) (Richardson et al.,mal in 2 out of 19 healthy donors. The results suggest
1994; Laochumroonvorapong et al., 1996), CD69 (Depossible genetic heterogeneity of this mechanism of
Maria et al., 1994), and addition of exogenous adenosinemycobacterial killing associated with P2Z-mediated
59-phosphate (ATP) (Molloy et al., 1994), were examinedpore formation.
for their effect on intracellular mycobacterial viability.
Only ATP was found to induce both cell death and killing
Introduction of intracellular mycobacteria within BCG-infected human
macrophages, confirming the seminal findings of Molloy
The continuing global public health problem of TB has
et al. (1994) and Laochumroonvorapong et al. (1996)
become acutely exacerbatedwith the recent emergence
that ATP-induced macrophage death by apoptosis isof multi-drug-resistant (MDR) strains of Mycobacterium
accompanied by the concomitant demise of intracellulartuberculosis (Malin and McAdam, 1995). New strategies
mycobacteria. The cell receptor, signaling pathway(s)are therefore urgently needed to combat this developing
and effector mechanism(s) mediating these ATP effectsclinical challenge. It has been estimated that a third of
were then further investigated.the world's population is infected by TB, but .90%
Extracellular ATP (ATPe) is known to act on cell sur-remain healthy; hence, the vast majority of immunocom-
face P2 receptors expressed on many tissues through-petent humans can control and contain this pathogen.
out the body. Six classes have been defined (P2Y, P2U,However, our understanding of the cellular and molecu-
P2D, P2X, P2T, and P2Z) from their agonist profile andlar interactionsbetween mycobacteria and host immune
sensitivity to inhibitors, and all have been cloned (Dicells, which results in this asymptomatic equilibrium, is
Virgilio, 1995; Surprenant et al., 1996). Macrophagesfar from complete but is essential if novel immunothera-
possess both P2Y and P2Z receptors (Nuttle et al.,peutic-based strategies are to be devised for treating
1993). P2Y are G-protein coupled receptors that acti-MDR TB.
vate a phosphinositide-specific phospholipase C signal-Mycobacteria are facultative intracellular parasites
ing cascade releasing Ca21 from internal stores (Dubyakthat are thought to replicate and be destroyed within
and El-Moatassim, 1993). P2Z receptors, like P2X, arehost macrophages. Observations in normal and gene-
disrupted mice show that optimum antimycobacterial ligand-gated cation channel receptors with a distinct
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Table 1. The Effects of Different Stimuli of Macrophage Death by Apoptosis and Necrosis on Intracellular BCG Viability
%m BCG Viability
Percentage of Specific Percentage of Specific
Donor Treatment Cytolysis (51Cr) Apoptosis 3H-Uridine CFU
1 ATP 34.2 27 257 260
2 ATP 16.1 21 270 255
C9 58.1 22 11 25
3 C9 78 21 19 15
4 C9 67 0 12 6
5 IFNg 1 6 24.9 15.3
ATP 1 IFNg 31 29 254.4 247
a-FAS 1 IFNg 35 53 34.3 12.2
6 IFNg 2 11 14.2 5.6
a-FAS 1 IFNg 27 53 14.1 11.7
7 IFNg ND 4 36.9 14.5
a-CD69 1 IFNg ND 29 27 17.1
BCG-infected MDMs derived from seven healthy donors were treated with or without rhIFNg (100 U/ml) at day 4 after culture, infected overnight
(16 hr) with BCG (5 bacteria/cell) at day 6 after culture, and treated with either ATPe (3 mM) for 30 min (donors 1 and 2) or fresh human
complement plus anti-HLA-DR antibody (10 mg/ml; donors 2±4) or IFNg with or without anti-CD95/Fas (200 ng/ml) or anti-CD69 antibodies
(10 mg/ml; donors 5±7) for 24 hr. The percentage of cytolysis (51Cr release) and BCG viability (3H-uridine/CFU) for each were then determined
24 hr after the final treatment step.
ND, experiment not done. %m, percentage change from control.
agonist profile. ATP/P2Z receptor engagement, how- and overlapping inhibitors were used in an attempt to
identify the relevant pathway.ever, is unique in triggering the formation of large nonse-
lective membrane pores permeable to hydrophilic mole- Finally, the possible effector mechanisms involved in
ATPe-mediated activity were also investigated. Recentcules with molecular mass ,0.9 kDa. Activation of this
specific P2 receptor subtype and subsequent pore for- data from animal models, human in vitro systems, and
immunohistochemistry studies have shown that themation is then thought to cause rapid cell death by
apoptosis (Di Virgilio, 1995). products of macrophage activation, that is, reactive oxy-
gen (ROI) and nitrogen (RNI) intermediates are the majorP2Z receptors have a limited expression, being pres-
ent on cells of immune and hemopoetic origin (Fredholm effector molecules involved in killing of intracellular
pathogens by macrophages (O'Brien et al., 1996). Weet al., 1994). Compared with other P2 receptors, a rela-
tively high concentration of ATP (in the millimolar range) therefore examined theeffects of ATPe on macrophages
isolated from healthy donors and from chronic granulo-is needed to activate the P2Z receptor at physiological
pH. This is attributed to the fact that only the fully ionized matous disease (CGD) patients, whose phagocytes are
inherently unable to generate an oxidative burst (Smithform of ATP (ATP42), present as a minor fraction at physi-
ological pH, appears to be the active ligand interacting and Curnutte, 1991), in the presence or absence of a
panel of specific RNI inhibitors.with the P2Z receptor. Based on protein sequence data,
the recently cloned rat and human P2Z receptors have
been reclassified into the P2X family and designated Results
P2X7 (Surprenant et al., 1996; Rassendren et al., 1997).
In human macrophages, the following nucleotides act The Effect of Macrophage-Induced Cell Death
on the Survival and Viabilityas agonists of P2Z receptors: Bz ATP .ATP. ATPgS
(Dubyak and El-Moatassim, 1993; Surprenant et al., of Intracellular BCG
Previous reports have demonstrated that human macro-1996), whereas GTP, UTP, and ADP have no effect (Di
Virgilio, 1995). Conversely, oxidized ATP (2,3 dialdehyde phages can be induced into apoptotic cell death after
treatment with antibodies to CD95 (Richardson et al.,ATP), a P2Z antagonist, binds irreversibly to this recep-
tor and prevents its activation by ATPe (Murgia et al., 1994) or CD69 (De Maria et al., 1994). In this study,
however, we demonstrate that intracellular BCG viability1993). Suramin, hexamethylene amiloride (HMA), and
the isoquinolinesuphonamide KN-62 are also known to is not reduced by macrophage apoptosis induced by
treatment of interferon-g±activated macrophages withblock ATP actions at P2Z receptors (Wiley et al., 1992,
1993; Gargett and Wiley, 1997). These ATP agonist and (1) anti-CD95 antibody, (2) anti-CD69 antibody, or (3) by
necrosis of BCG-infected macrophages by treatmentantagonist profiles were therefore used to determine
whether the ATP-mediated cytocidal and mycobacteri- with anti-MHC class II antibody and complement (Table
1). However it has also been reported that macrophagescidal effects on BCG-infected human macrophages
were specifically associated with activation of the P2Z can be induced to die by ATPe (Molloy et al., 1994; Di
Virgilio, 1995) although there is some controversy overreceptor.
In addition, to identify the signaling pathway(s) by whether this occurs by apoptosis (Molloy et al., 1994)
or by necrosis (Blanchard et al., 1995). We then investi-which ATPe induced killing of macrophage and intracel-
lular BCG, we investigated the influence of a panel of gated the effect of extracellular ATP on the viability of
BCG-infected macrophages.candidate metabolic inhibitors. Because many of these
compounds affect multiple pathways, several similar Figure 1a illustrates that macrophages start to lose
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intracellular BCG depends on events within the cells
(Table 2).
Figure 2a illustrates the results obtained when TUNEL
assays were performed to confirm the morphologically
determined kinetics of cellular apoptosis observed
within ATPe-treated human macrophage cultures. The
results (Figures 2a±2h) illustrate the increasing percent-
age of TUNEL-positive cells with time over 0.5±6 hr.
We conclude from the morphological and TUNEL data
that ATPe engagement of the P2Z receptor triggers
apoptosis within human 7-day-cultured macrophages.
The 51Cr release data and the degree and kinetics of
cell death observed, however, suggest that macrophage
apoptosis quickly degenerates into secondary necrosis.
The kinetics of apoptosis and necrosis within a given cell
population were also observed to vary widely between
individual donors (D. A. L., personal communication).
Differences in the relative percentages of each form of
cell death within a population were then thought to re-
flect the mean density of P2Z expression within individ-
ual cell populations.
Evidence that ATP-Induced Macrophage Death
and Concomitant BCG Death Is Mediated by
Purinergic P2Z Receptors
A number of agonists and antagonists of the P2Z recep-Figure 1. Kinetics of Cell Death, Apoptosis and Killing of Intracellu-
lar BCG after Treatment of BCG-Infected MDMs with ATP. tor were used in these assays to demonstrate the
BCG-infected MDMs were preactivated with rhINg (100 U/ml) at day involvement of this specific P2 receptor subtype in the
4 after culture. The cells were then infected with BCG (5:1 bact/cell) ATPe-mediated responses. Only the most effective con-
at day 6 after culture and simultaneously labeled with 51Cr (2 mCi/ centration (underlined) is illustrated for clarity, whereas
well) and incubated overnight (16 hr). The cells were then treated
the concentration range of each agent tested is depictedwith 3 mM ATP for 30 min on day 7 after culture. The kinetics of
in parenthesis. The results (Figure 3) demonstrate thatcell death 51Cr-release, (a) apoptosis (acridine orange staining of
the cytotoxic and mycobactericidal activity of ATPe (0.5,coverslip cultures) (b) and BCG viability, determined by 3H-uridine
incorporation by the bacteria (c) and CFU estimation (d), were moni- 1, 3, 5 mM) areboth mediated via P2Z receptor activation
tored at time (hr) after treatment. All experiments were carried out because these are not produced by other nucleotides
on two to four separate occasions with triplicate observations made such as UTP, UDP, GTP, and AMP (0.5, 1, 3, and 5 mM)
for each experiment. The symbols indicate mean values, and vertical
(Figure 3a), which stimulate P2Y but not P2Z receptorsbars indicate the standard error.
(Gordon, 1986).
The ATPe effects can also be induced by the ATP
analogues benzoylbenzoic ATP (BzATP) (0.1, 0.5, 2, 3,
viability by 2 hr after a 30-min pulse of ATPe, reaching and 5 mM) and ATPgS (0.1, 0.5, 2, 3, and 5 mM) (Figure
a peak (48%) by 6 hr. Morphologically determined per- 3b), which are specific agonists of P2Z receptors. ATPe
centage apoptosis rose similarly (Figure 1b), although activity is also potentiated by extracellular Zn21 (10, 100,
the degree of cell death detected by 51Cr release is sub- and 500 mM) (Di Virgilio, 1995) (Figure 3b), which ampli-
stantially higher throughout. This was attributed either to fies the ion channel±opening effect of ATPe on macro-
the morphological changes of apoptosis lagging behind phages with increased death of intracellular bacteria.
51Cr release or to the involvement of both apoptosis and Furthermore, these effects can be blocked by pretreat-
necrosis in this process, as previously described (Molloy ment of the macrophages with oxidized ATP (oATP) (30,
et al., 1994; Blanchard et al., 1995). The morphological 300, and 500 mM) (IC50 0.9 mM), which is an irreversible
features used to assess apoptosis within acridine or- antagonist of P2Z receptors (Murgia et al., 1993) and
ange±stained ATP-treated macrophage cultures in- antagonized by extracellular Mg21 (10 and 25 mM),
cluded cell shrinkage, granulation of the cytoplasm, and which chelates ATP42, the active component of ATPe
the presence of acentric nuclei. BCG viability, as deter- interacting with P2Z receptors (Richardson et al., 1994),
mined by radiometric (Figure 1c) and CFU counting and by suramin (101, 102, and 103 mM) (IC50 60 mM), a
methods (Figure 1d), fell after 30 min of ATPe pulsing, pan-P2 purinergic receptor inhibitor (Wiley et al., 1993).
with a net reduction of z60% at 4 hr. The duration of 3 They are also inhibited by amiloride 59(N-methyl-N-iso-
mM ATPe exposure required to initiate macrophage and butyl)-MIA (10, 50 and 100 mM) (IC50 2±10 mM) (Wiley et
intracellular BCG death was found to be a minimum of al., 1992) and DIDS (100±200 mM) (El-Moatassim and
5 min, with the process plateauing by 30 min of ATPe Dubyak, 1993), which are anion channel blockers that
exposure (data not shown). Extracellular BCG ex- competitively inhibit P2Z receptor±mediated events
posed to 3 mM ATPe or to cell lysate from ATP-pulsed (Figure 3c). Both ATPe-mediated effects (macrophage
death and killing of intracellular BCG) were also blockedmacrophages do not die, indicating that the killing of
Immunity
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Table 2. Experiments Demonstrating that the Mycobactericidal Activity of ATPe Is Not Due To Any Direct Toxic Effect on Extracellular
BCG.
3H-Uridine % m BCG %mBCG
Experiment Treatment Uptake (dpm) Viability (3H-Uridine) BCG (CFU/ml) Viability (CFU)
ATP(3 mM)
1 0 hr 4,013 54
0.5 hr 40,938 2 56 4
2.0 hr 38,445 24 56 4
4.0 hr 38,992 23 50 27
6.0 hr 38,992 23 56 4
2 Cell Lysate (a)
Medium Alone 2,000








1:8 2,200 10 ND ND
1:4 3,200 60
1:2 14,000 700
In experiment 1, aliquots of 106 BCG were incubated with or without 3mM ATP for 0.5, 2, 4, and 6 hr in RPMI-1640 medium plus 10% A1
serum. The bacteria were then resuspended in 7H9 broth plus 10% ADC, and BCG growth was determined by both 3H-uridine incorporation
over 72 hr and by CFU estimation over 10 days.
In experiment 2, MDMs of normal healthy donors were treated with either 3mM ATP (a), complement (b), or medium alone (c) for 30 min. After
6 hr the cell pellets were lysed by repeat freeze-thawing, and serial dilutions of each were added to an equal volume of BCG (5 3 105 bacilli)
in 7H9 broth plus 10% ADC. Bacterial growth was then assessed by 3H-uridine incorporation over 72 hr and CFU estimation over 10 days.
ND, experiment not done. %m, percentage of change from control.
by the Ca21/calmodulin-dependent protein kinase II Role of RNI and ROI in ATP-Mediated Death
of Macrophages and of Intracellular BCG(CaMKII) inhibitor KN-62 (0.1, 5 and 9 mM), a known
inhibitor of P2Z receptors (Gargett and Wiley, 1997; The results presented in Table 3 show that ATPe-medi-
ated cell lysis (51Cr release) or BCG killing (3H-uridineHumphreys and Dubyak, 1996). The data in total indicate
that ATPe causes macrophage and intracellular cell incorporation or CFU estimation) were also not blocked
by inhibitors of inducible nitric oxide synthetase (iNOS).death specifically through the P2Z receptor.
A panel of metabolic inhibitors was used in attempt For clarity, the results illustrated are given for one con-
centration only (underlined), although a range of titra-to identify the signaling pathways by which ATPe/P2Z-
stimulated responses were mediated. However, none of tions was evaluated (shown in parentheses). These
included L-NMMA (1, 10, and 500 mM) (IC50 5 10 mM),the inhibitors tested were found to affect either ATPe/
P2Z-induced cell death or killing of intracellular BCG L-N5-(1-iominoethyl) ornithine hydrochloride (L-N5IOH)
(0.02, 0.2, and 2 mM) (Ki 5 0.2 mM), and NG-nitro-L-(results not shown). Each of the inhibitors was assayed
at a range of concentrations, shown in parentheses, arginine (NGNLA) (0.05, 0.5, and 5 mM) (IC50 5 0.5 mM),
ranges equivalent to concentrations 10-fold above andbased on their Ki or IC50 values. These included EGTA
(0.1, 0.2, 0.3 and mM) (a chelator of extracellular Ca21), below the Ki for these compounds (Reif and McCreedy,
1995). In addition ATPe activity was demonstrated tothapsigargin (102, 103, and 104 nM) (which causes release
of intracellular Ca21 stores by inhibiting Ca21-ATPase occur in BCG-infected macrophages derived from one
patient with X-linked CGD and from two patients withof the endoplasmic reticulum; Thastrup et al., 1989);
staurosporine (0.1, 0.5, and 1 mM) and chelerythrine (0.1, autosomal recessive CGD (Table 4); in these patients,
phagocytes are unable to generate an oxidative burst0.5, and 1 mM) (both potent inhibitors of PKC) (Tamaoki
et al., 1986), genistein (1, 5, 10, 50, and 100 mM) (an (Smith and Curnutte, 1991). One of the autosomal reces-
sive CGD patients (AR-CGD1) also responded similarlyinhibitor of protein tyrosine kinases) (Bronte et al., 1996),
pertussis toxin (0.5, 1, and 2 mg/ml) (an inhibitor of ade- to ATPe treatment after preincubation with the iNOS
inhibitor LN10 (Table 4). These results demonstrate thatnylate cyclase activity via inhibition of Gi protein-depen-
dent activation) (Dubyak and El-Moatassim, 1993), and neither ROI norRNI are the effector molecules mediating
intracellular bacterial killing or cell lysis initiated by ATPeactinomycin D (2.5, 5, and 7.5 mg/ml) and cycloheximide
(10, 25, and 50 mM) (Laochumroomvorapong et al., 1996) engagement of the P2Z receptor.
(inhibitors of protein translation and transcription, re-
spectively). The negative results obtained with all of Heterogeneity of ATP-Receptor Expression on
Human Monocyte±Derived Macrophagesthese inhibitors suggest that ATPe/P2Z-associated ac-
tivity does not involve downstream signaling pathways from Different Donors
We observed marked heterogeneity in individual donorsto effect pore formation and subsequent cell death and
killing of intracellular mycobacteria. in the susceptibility of their macrophages to in vitro
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or without IFNg preactivation (donors 11±19); and (3)
those showing a positive response to ATPe, which in-
creases on preactivation with IFNg (donors 3±10).
Heterogeneity of macrophage susceptibility to ATPe
was shown to be mirrored by changes in the viability of
intracellular BCG within macrophages (Figure 5b). The
two donors (1 and 2) who failed to show ATPe-induced
macrophage death despite activation with IFN-g (Fig-
ures 4 and 5a) also show low levels of concomitant BCG
killing (Figure 5b) and poor lucifer yellow dye uptake
(molecular mass 460 Da) (Figure 5c), the latter being
indicative of the failure of the cells to form secondary
pores in response to ATPe stimulation.
In contrast, 7-day macrophage monolayers derived
from either high-ATPe responders (donors 17 and 19)
or from donors able to upregulate their response to
ATPe after preactivation with IFN-g (donors 3 and 7)
showed marked macrophage cell lysis (Figure 5a) and
BCG killing (Figure 5b) and contained markedly more
cells capable of taking up lucifer yellow dye (Figure 5c).
Furthermore, within reactive cells, when the dye was
removed from the extracellular medium, the lucifer yel-
low was shown by confocal microscopy to be trans-
ported into large, discrete vacuoles (results not shown),
similar to the apparent trapping of intracellular BCG into
cytoplasmic vesicles observed previously by electron
microscopy of infected ATPe-treated cells (Molloy et al.,
1994; results not shown).
The differential response of macrophages to ATP
treatment was shown to be P2Z receptor mediated, be-
cause cell death, BCG killing, and lucifer yellow dye
uptake were all blocked within responder donors after
pretreatment of cells with oATP (Figures 5a-5c).
The ATP response categories of each donor were
found to remain stable over 1 year of repetition (D. A. L.,
unpublished observation). The results suggest possible
genetic heterogeneity in P2Z receptor expression and/
or function among individuals within a population.
Discussion
In this study, we demonstrate that ATPe can induce both
Figure 2. TUNEL Assay Assessment of Apoptosis within Monocyte- rapid cell death and killing of intracellular mycobacteria
Derived Macrophage Cultures with Time after ATPe Treatment
within BCG-infected human macrophages, confirming
Apoptotic macrophages were identified by TUNEL assay as fluores-
the important initial observation of Molloy et al. (1994).cent positively labeled cells. These were assessed as a percentage
We also illustrate that the cytotoxic and mycobacterici-of the total cell population (determined by phase contrast) with time
dal activity of ATPe does not result from any non-spe-after treatment. Time points illustrated: 0 hr (a and b), 1 hr (c and
d), 4 hr (e and f) and 6 hr (g and h). DNase-treated and nontreated cific perturbation of the cell membrane or to a direct
monolayers were included as positive (i and j) and negative controls toxic effect of ATPe onthe bacteria. However, the effects
(k and l). are shown to be mediated by the specific interaction of
ATPe with the macrophage surface P2Z (P2X7) receptor,
because they could be mimicked or inhibited by P2ZATPe-mediated cytotoxicity. Figure 4 illustrates the ac-
cumulated data demonstrating that in 8 of 19 individual agonists and antagonists, respectively.
Macrophage activation is known to increase the sur-donors, pretreatment with IFNg rendered cells signifi-
cantly more sensitive to ATPe-induced killing compared face expression of apoptosis-inducing receptors such
as CD95 (Richardson et al., 1994) and CD69 (De Mariawith unactivated macrophages. In addition, Figure 5 also
shows that susceptibility to ATPe-mediated lysis of et al., 1994) as well as induce upregulation of P2Z (P2X7)
expression (Humphreys and Dubyak, 1996). Activationmacrophages derived from monocytes cultured in vitro
for 7 days could be used to categorize healthy donors predisposes such cells to various optional pathways of
immune-mediated cell death.into three groups: (1) those showing little response to
ATPe in the presence or absence of IFN-g (donors 1 Our results demonstrate that in vitro, however, apo-
ptosis induced by CD95 or CD69 ligation or necrosisand 2); (2) those exhibiting a high response to ATPe with
Immunity
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Figure 3. ATP-Induced Cytolytic and Myco-
bactericidal Effects are P2Z ReceptorÐ
Mediated Events.
ATP-mediated cell lysis and intracellular BCG
killing are shown to occur specifically via trig-
gering of the macrophage P2Z purinergic re-
ceptor on 7-day cultured human macro-
phages by their response profile to different
purine nucleotides (a), and to a panel of spe-
cific agonists (b) and antagonists (c) of the
P2Z receptor. Where appropriate, cell cul-
tures were preincubated with agonists and
antagonists for 15 min before addition of ATP
or other nucleotides for 30 min, with the ex-
ceptions of amiloride and oATP, which were
added 2 hr before ATP. The cells were then
washed in complete medium, and cell death
(% specific cytotoxicity [h]) and BCG viability
(% reduction of BCG CFU [j]) were then de-
termined at 24 hr after-treatment.
(a) Cells were treated with 3 mM ATP (i), ADP
(ii), UTP (iii), GTP (iv), or AMP (v).
(b) Cells were treated with 3 mM ATP, pH 7.0
(i), BzATP (ii), ATPgS (iv), or 500 mM Zn21 (v).
(c) Cells were treated with 3 mM ATP, pH 7.0
(i), 300 mM oATP with or without ATP (ii), 10
mM Mg21 with or without ATP (iii), 1 mM sura-
min with or without ATP (iv), 10 mM amiloride
with or without ATP (v), 200 mM DIDS with or
without ATP (vi), 5 mM KN-62 with or without
ATP (vii).
induced by complement (Table 1) does not directly influ- Wiley, 1997), but acts intracellularly, conferring specific-
ity by binding to the long intracellular carboxyl tail foundence intracellular bacterial survival. Laochumroonvora-
pong et al. (1996) also demonstrated that macrophage only on the P2Z (P2X7) receptor (Surprenant et al., 1996),
or close to one of the transmembrane regions preventingapoptosis induced by CD95 ligation H2O2 (10 mM) did
not reduce the viability of intracellular M. avium±M. intra- ATP-induced conformational changes associated with
ion channel opening (Gargett and Wiley, 1997). How-cellulare. Taken together, these data suggest that not
all forms of macrophage death result in the demise of ever, a role for phospholipase D (PLD) in mediating the
ATPe-associated effects cannot as yet be ruled out,intracellular mycobacteria.
The specific signaling pathways involved in ATP- because PLD activation has been reported tooccur after
P2Z receptor stimulation in both murine (El-Moatassimmediated death of macrophages and killing of intracellu-
lar BCG remain to be determined. However, we demon- and Dubyak, 1993) and human macrophage cell lines
(Humphreys and Dubyak, 1996). We are currently in-strate that ATPe effects do not involve activation of PKC,
protein tyrosine kinases, intracellular Ca21 release, or vestigating the effects of PLD inhibition on P2Z-associ-
ated cytocidal and mycobactericidal events.adenylate cyclase activity. The marked inhibitory effect
of KN-62 observed in this study supports a previous Our results show that ATP-mediated macrophage
death and bacterial killing are both independent of RNIreport that ATP-dependent CD81 T cell±mediated cytol-
ysis is KN-62 dependent (Blanchard et al., 1995). The and ROI. The lack of effect of actinomycin D and cyclo-
heximide, inhibitors of protein transcription and transla-inhibitory effect of KN-62 on ATP activation of human
lymphocyte P2Z receptors has recently been shown not tion, respectively, on ATPe-mediated macrophage or
bacterialdeath also indicate that denovo synthesis doesto be due to specific CaMKII inhibition (Gargett and
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Table 3. Role of RNI in the Effector Pathway(s) Involved in ATPe-Mediated Macrophage Cell Death and Killing of Intracellular BCG
within Infected Human Macrophages
Percentage of % m BCG Viability
Specific Cy-
Experiment Treatment tolysis (51Cr) 3H-Uridine CFU
1 L-LMMA 5 27.5 22.3
L-NMMA 1 ATP 51 273.2 265.4
ATP 54.3 276.6 264.9
2 LN-10 0.2 232.3 21
LN-10 1 ATP 23.2 278.8 244.3
ATP 21.1 275.7 240.6
3 L-Arg 1 226.4 23.4
L-Arg 1 ATP 33.2 262.4 242
ATP 32 272.4 249.3
The role of RNI in mediating ATP-induced cell death and intracellular BCG-killing was evaluated. BCG infected MDMs were pretreated with
a panel of specific iNOS inhibitors including ATP with or without 2 mM L-NMMA, ATP with or without 5 mM L-N5-(1-iminoethyl)-ornithine (LN-
10), and ATP with or without 2 mM NG nitro-L-arginine (L-Arg) and then screened for inhibition of ATPe activity.
MDMs were pretreated overnight (18 hr) with inhibitors before incubation with 3mM ATP for 30 mins. Cell lysis (51Cr release) and BCG viability
(3H-uridine incorporation and CFU determination) were then determined at 24 hr after treatment.
% m, percentage of change from medium control.
not appear to be required for its activity, suggesting that P2Z receptor±mediated cytolysis per se, cannot explain
the mediator(s) involved are preformed within the cell. the mycobactericidal actions of ATPe. The effector
In addition, apoptosis by CD95 or CD69 ligation did not mechanism(s) initiated by ATPe engagement of P2Z re-
influence intracellular bacterial survival. P2Z-associated ceptors on the surface of infected macrophages in-
cytotoxic and bactericidal activity are also unaffected volves a previously undefined and entirely novel myco-
by interleukin converting enzyme (ICE) inhibitors (C. S. bactericidal process.
and D. A. L., manuscript in preparation). Taken together, Electron microscopy studies have revealed that
these observations suggest that biochemical events as- ATP-induced cell death of BCG-infected human macro-
sociated with cellular apoptosis, including ICE activa- phages is associated with the formation of large cyto-
tion, and the previously recognized antibacterial effector plasmic vacuoles into which intracellular bacteria co-
mechanisms associated with macrophages (i.e., toxic alesce (Molloy et al., 1994; and our own observations).
O2 and nitric oxide intermediates) are not involved in We speculate therefore that P2Z receptor signaling may
ATPe-associated activity. Lack of effect on intracellular promote phagosome±lysosome fusion and/or changes
viability by complement-mediated lysis suggests that in the pH of the phagosome, resulting in the destruction
of the intracellular mycobacteria. Interestingly, ATP-
induced multiple endosome formation and subsequent
endosome±lysosome fusion has been previously de-
scribed to occur in ATPe-treated J774 murine cells
(Steinberg et al., 1988). Experiments are ongoing in our
laboratory to investigate the occurrence and possible
relevance of this phenomenon within mycobacterial-
infected human macrophages by use of time-lapse con-
focal microscopy with a panel of molecular probes.
It has been estimated that only 10% of TB-infected
individuals actually suffer from clinical disease (Snider
and La Montagne, 1994). This suggests that the vast
majority of infected immunocompetent individuals are
capable of controlling or containing an infection. The
underlying causes of disease progression to clinical TB
are multifactorial but are known to involve genetic influ-
ences on individual susceptibility and resistance to in-
fection (reviewed in Stead, 1992). Interestingly, in this
study, we present preliminary data indicating that theFigure 4. Heterogeneity of ATPe-Mediated Cytotoxicity Response
macrophages from 2 out of 19 healthy individuals showwithin Human Monocyte±Derived Macrophage Cultures Derived
from Different Healthy Donors a high degree of resistance to ATP-mediated cell death
Four-day cultured MDMs were prepared from 19 different healthy and concomitant killing of intracellular BCG.
donors and incubated with or without rhIFNg (100 U/ml) for 2 days. It has been previously reported that pretreatment with
The cells were then treated with 3 mM ATP for 30 min and then IFNg renders human macrophages more sensitive to
incubated for 16 hr. Cell death (% specific chromium release) was
ATPe-induced killing compared with nonactivated cellsthen determined for each donor, and the results were ranked arbi-
(Blanchard et al., 1991). Our results confirm that, withintrarily into three groups on the basis of their differential response
to ATPe in the presence or absence of rhIFNg. many individual donors, pretreatment with IFNg renders
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Table 4. Role of ROI in the Effector Pathway(s) Involved in ATPe-Mediated Macrophage Cell Death and Killing of Intracellular BCG
within Infected Human Macrophages
Percentage of Specific % m BCG
Experiment Subject Treatment Cytolysis (51Cr) Viability (CFU)
1 X-CGD ATP 30 241
IFNg 4 232
ATP 1 IFNg 50 236.8
HD1 ATP 26 265.8
IFNg 3 15.8
ATP 1 IFNg 48 250
2 AR-CGD1 ATP 22 244.3
IFNg 5 188.6
ATP 1 IFNg 31 260.2
LN10 21 23.3
LN10 1 IFNg 2 170
ATP 1 LN10 1 IFNg 34 230.9
3 AR-CGD2 ATP 17 236.2
IFNg 2 148.3
ATP 1 IFNg 24 251.7
HD2 ATP 26 240.8
IFNg 4 241.5
ATP 1 IFNg 34 262.3
MDM's from three CGD patients; one x-linked CGD patient (X-CGD), two autosomal recessive patients (AR-CGD), and two unrelated healthy
donors (HD) were treated with rhIFNg (100 U/ml) at day 4 after culture, infected overnight (16 hr) with BCG (5:1) at day 6 after culture, and
treated with 3 mM ATP for 30 min on day 7 after culture. The cells were then assessed for percentage of cytolysis by 51Cr-release assay and
BCG viability by CFU estimation. MDMs from patient AR-CGD1 were also pretreated for 16 hr with 5 mM L-N5-(1-iminoethyl)-ornithine (LN-10)
for 24 hr before the addition of ATP.
% m, percentage of change from control.
macrophages and the intracellular BCG within them sig- ATPe/P2Z-mediated killing of IFNg-activated human
nificantly more sensitive to ATPe-induced killing com- monocyte±derived macrophages and murine perito-
pared with unactivated cells. We speculate that in such neal-derived macrophages was found to be as effective
cells, P2Z expression is upregulated after IFNg activa- in killing virulent H37Rv M.tb as avirulent BCG (D. A. L.
tion. This is supported by the recent finding that activa- et al., manuscript in preparation). If P2Z receptors prove
tion of THP-1 cells by a combination of IFNg and LPS to be involved in host immunity to TB, then resistance
resulted in bothan enhanced cytolytic response to ATPe to disease may be more attributable to initiation of an
and an increase in P2Z mRNA transcription levels (Hum- appropriate cellular response (in terms of receptor acti-
phreys and Dubyak, 1996). However, in an equivalent vation) than to the virulence of the organism. If con-
number of donors examined, we found that preactiva- firmed, our preliminary evidence suggesting possible
tion of macrophages with IFNg gave no additional en- genetic heterogeneity of P2Z receptor activity may
hancement of ATPe-mediated effects. We hypothesize prove to bea further polymorphism influencing suscepti-
that such cells inherently exhibit optimal P2Z expres- bility to intracellular bacterial infection.
sion. Conversely, in cells from 2 out of 19 individuals The physiological role of ATPe and the P2Z receptors
examined, ATPe had little or no effect, suggesting that in granulomatous inflammation is speculative. The asso-
such cells have poor or low P2Z receptor expression. ciation of lack of macrophage death and multibacillary
Cells derived from ªhighº and ªlowº ATPe responders, disease in immunodeficent patients and the paucibacil-
however, showed similar Ca21 signaling intensities after lary nature of closed caseous lesions in immunocompe-
challenge with ATPe, indicating similar receptor expres- tent individuals suggests that macrophage death is part
sion (C. S. and D. A. L., manuscript in preparation). Poor of a protective cellular immune response to mycobacte-
responder cells displayed poor uptake of lucifer yellow
rial infection. The relative proportions of macrophage
dye in the presence of ATPe, suggesting that these cells
death induced by different mechanisms occurring within
have normal P2Z receptor expression and Ca21 signaling
a tuberculous granuloma may influence the balance be-
function but defective secondary pore formation.
tween net bacterial destruction and growth. Interest-The rat and human P2Z receptors have been cloned
ingly, similar levels of leukocyte apoptosis have beenand shown to contain a long intracellular carboxyl-termi-
observed to occur within granulomata in Fas recep-nal domain not found in other P2X subtypes. This con-
tor±defective and control mice after infection with M.tbfers the unique permeability of P2Z channels to large
(Laochumroonvorapong et al., 1997). This suggests thatcations, such as the fluorescent dye lucifer yellow (Sur-
an alternative apoptotic/cell death pathway(s) contrib-prenant et al., 1996; Rassendren et al., 1997). The human
utes to cell turnover within a TB granuloma.P2Z gene is known to be composed of 12 exons (Buell
ATPe has been previously reported to be releasedet al., 1997). We are currently sequencing the P2Z exons
during interaction between macrophages and CTL pos-from defined high- and low-responder individuals to look
sibly allowing high local concentrations of this chemicalfor a possible genetic basis for the observed heteroge-
to be achieved within a granuloma (Di Virgilio et al.,neity in ATPe response phenotype, especially in the
exons coding for the C-terminal tail region. 1990; Di Virgilio, 1995). CD41, CD81 and gd T cells can
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in results from DNA vaccination studies in mice for in-
ducing resistance to challenge with M.tb (Tascon et al.,
1996). In contrast, studies in Fas and Perforin knockout
mice have suggested that neither of these mechanisms
of potential CTL-mediated target cell death play a major
role in the control of M.tb infection in vivo (Laochum-
roonvorapong et al., 1997). Two recently described hu-
man CD1-restricted T cell lines, one CD42CD82 and the
other CD81, were reported to efficiently lyse macro-
phages infected with M. tuberculosis (Stenger et al.,
1997). The cytotoxicity of the CD42CD82 T cells was
mediated by Fas±FasL interaction and had no effect on
the viability of the mycobacteria. The CD81 T cells lysed
infected macrophages by a Fas-independent, granule-
dependent mechanism that resulted in killing of the
mycobacteria (Stenger et al., 1997). In reference to the
previously reported perforin knockout mice studies
(Laochumroonvorapong et al., 1997), the latter authors
concluded that the antimicrobacterial activity displayed
by their CD81 T cells may be independent of the lytic
process or due to additional mediators in the cytotoxic
granules (Stenger et al., 1997).
Interestingly, human CD81 T cells stimulated with
staphylococcal enterotoxin have been reported to kill
enterotoxin pulsed macrophages by exocytosis of ATP
(Blanchard et al., 1995). CTL are also known to be resis-
tant to ATP-induced permeabilization due to a combina-
tion of low P2Z receptor and high ecto-ATPase expres-
sion (Filippini et al., 1990).
Conversely, macrophages, whenactivated, areknown
to lose their ecto-ATPase activity (Adams and Hamilton,
1984) while simultaneously upregulating their P2Z re-
ceptor expression (Humphreys and Dubyak, 1996).
Thus, on activation, they become more sensitive to the
cytolytic properties of ATPe. ATPe responsiveness and
hence P2Z expression can be modulated by activation
with IFNg (Blanchard et al., 1991), LPS (Di Virgilio, 1995),
IFNg and LPS (Humphreys and Dubyak, 1996), and my-
cobacterial LAMs (D. A. L. and R. R. Mathews, manu-
script inpreparation). Indeed, P2Z receptor upregulation
appears to be an inevitable concomitant of optimal mac-Figure 5. Correlation of Cell Lysis, Intracellular Mycobacterial Via-
bility and Lucifer Yellow Dye Uptake, within Cells from Six Healthy rophage activation. Moreover, high mycobacterial bur-
Donors Demonstrating Heterogeneity in Response to ATPe dens also predispose macrophages to ATPe-mediated
MDM cultures were prepared from six donors (donor 1, 2, 3, 7, 17 killing (D. A. L. and R. R. Mathews manuscript in prepa-
and 19) chosen from the original panel of 19 healthy donors as being ration).
representative of the three characterized ATP-response pheno- The intracellular concentration of ATP is between 5
types. Cells were preactivated on day 4 with 100 U/ml rhINFg, in-
and 10 mmol; hence, cell death, as would occur in anfected 6 days after culture with BCG for 16 hr at an infection ratio
inflammatory focus, could liberate ATP, resulting in highof 5 bacteria/cell, and then treated with or without 0.3 mM oATP
local concentrations (cf. 3 mM) (Di Virgilio, 1995). Infor 2 hr before addition of 3 mM ATP for 30 min. The cells were then
incubated for 16 hr, and the percentage of cell death (a) and the addition, human macrophages have recently been re-
percentage of reduction in BCG viability (b) were determined for ported to release ATP after LPS stimulation (Ferrari et
each donor by 51Cr release assay and CFU estimation, respectively. al., 1997), which may have a role in stimulating P2Z on
In addition, cultures of uninfected MDMs from each donor were
neighboring high receptor±expressing cells after IFNgtreated with 3 mM ATP for 10 min in the presence of lucifer yellow
activation. ATPe-mediated P2Z receptor activation isdye, and the percentage of positively staining cells within a popula-
known to trigger a large and rapid release of mature IL-tion was quantified by visual assessment using a fluorescence mi-
croscope (c). 1B from human macrophages (Ferrari et al., 1997). ATPe
release in response to bacterial endotoxin or mycobac-
terial LAM by macrophages and subsequent autocrine/
be shown to be cytolytic to macrophages bearing myco- paracrine activation of P2Z receptors may be an impor-
bacterial antigens (Orme, 1996) and to be present within tant initiation system in the inflammatory process.
granulomatous lesions (Kaufmann, 1993). Furthermore, A speculative role for ATPe and P2 receptors in TB
the importance of cytolytic T cells (especially CD81) in granuloma formation can also be proposed from the
fact that P2Z receptors have been associated with giantimmunity to M.tb infection has recently been highlighted
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and the cells were incubated for 2±16 hr. The supernatants werecell formation (Falzoni et al., 1995). Furthermore, ATPe-
then aspirated from individual wells into LP2 plastic counting tubesmediated fibroblast activation via P2Y receptor engage-
(Appelton Woods, Birmingham, UK). Aliquots of 150 ml 1% Tritonment (Gonzalez et al., 1990) is known to trigger collagen
X-100 (Sigma), were then added to each cell pellet and incubated
secretion and cell division, which may promote granu- for 30 min at 378C to lyse the remaining adherent cells. The entire
loma formation in vivo. Moreover, within a granuloma, volume was subsequently aspirated and transferred to another
counting tube. The tubes were then sealed with wax, and the activityATPe-induced death of macrophages may initiate a cas-
of both the supernatant and pellet was assessed by measurementcade of events resulting in a substantial proportion of
of radioactive decay with a gamma counter (LKB, Selsdon, UK).bacteria, contained within dying cells, being killed.
In summary, we have extended the important obser-
Morphological Detection of Apoptosis
vations from the laboratory of Kaplan et al. that ATPe- by Acridine Orange Staining
initiated antimycobacterial activity occurring with human Macrophage apoptosis was also determined by morphological crite-
macrophages operates via cell surface P2Z receptors. ria after staining of the MDM coverslip cultures with the fluorescent
DNA binding dye acridine orange, (8 mg/ml in PBS). The cells wereThe bacterial death is independent of ROI, the genera-
fixed before staining in a 1% formaldehyde solution plus 6% FCStion of reactive nitrogen species, and ICE but probably
and stored at 48C. At least 200 cells from each coverslip cultureacts via a preformed mediator. Elucidation of the bacte-
were then scored as either viable or apoptotic on the basis of nuclear
rial killing mechanism initiated by this receptor may help morphology by using a fluorescent microscope (3400 magnifica-
us to devise new strategies to combat this most potent tion). The morphological criteria used to distinguish and identify
and enduring of human pathogens. apoptotic macrophages were as follows: Apoptotic cells were char-
acteristically much smaller and rounder than nonapoptotic macro-
phages and had granular cytoplasm and condensed acentric nucleiExperimental Procedures
(Gorman et al., 1996).
Reagents
Lucifer Yellow StainingBenzoylbenzoic-adenosine 59-triphosphate (BzATP), adenosine-59-
ATP stimulation of P2Z receptor±mediated pore formation was ob-o-(39-thiophosphate) (ATPgS), zinc sulfate heptahydrate, adenosine
served andquantified by lucifer yellow dye uptake by using a method59-triphosphate periodate oxidized (oATP), uridine 59-triphosphate
adapted from that originally described by Steinberg et al. (1988).(UTP), adenosine 59-monophosphate (AMP), adenosine 59-diphos-
Briefly, within monocyte-derived macrophages isolated from sixphate (ADP), guanosine 59-triphosphate (GTP), acridine orange (AO),
healthy donors cultured for 7 days on 13-mm glass coverslips (Brit-DIDS, and catalase were purchased from Sigma (Poole, UK). Thapsi-
ish Drug Houses, Poole, UK) in RPMI-1640 medium plus 10% AB1gargin and amiloride 59-(N-methyl-N-isobutyl)-MIA were purchased
human serum. Immediately before assessment, the coverslip cul-from Research Biochemicals International. Adenosine 59-triphos-
tures were washed twice and resuspended in 435 ml of RPMI-1640phate sodium salt (ATP) was purchased from Boehringer Mannheim
in 24-well tissue culture plates (Costar). To each culture was added(Indianapolis, IN). KN-62, NG-nitro-L-arginine, L-N5-(1-iminoethyl)
50 ml of 30 mM ATP solution (pH 7.2) (final 3 mM), 5 ml of a 25 mMornithine hydrochloride, NG-monomethyl-L-arginine monoacetate
sulfinpyrozone solution in DMSO (final 250 mm), and 10 ml of a 25-salt (L-NMMA), and NG-monomethyl-D-arginine monoacetate salt
mg/ml lucifer yellow (LY) solution (final 500 mg/ml). The cells were(D-NMMA) were purchased from Calbiochem-Novabiochem UK.
then incubated at 378C for 10 min, and the ATP and excess LY were
rinsed off the coverslip cultures in 43 changes of medium (PBSBacille Calmette-Guerin (BCG) Culture
plus 250 mm final sulfinpyrazone). The coverslips were then placedStock cultures of BCG (Evans strain) were maintained in log phase
on glass slides, 25-ml aliquots of PBS plus sulfinpyrazone (finalgrowth in Middlebrook 7H9 broth (Difco, Detroit, MI) supplemented
250 mm) were added to each, and a coverslip was added beforewith 10% Middlebrook ADC enrichment media (Difco) and 0.02%
observation under a fluorescence microscope. When assaying theTween (Difco) at 378C. The concentration of the BCG stock was
effects of oxidized ATP, the oATP (final 0.3 mM) in RPMI-1640 wasdetermined by direct counting using a Thoma counting chamber
added 2 hr before the addition of ATPe. The total number of cells(Weber Scientific UK) under dark ground illumination. Intracellular
per fieldwas then determinedunder phase contrast illumination, andBCG viability was determined by radiolabeling and microcolony
the number of lucifer yellow positive-staining cells was determinedcounting techniques, as previously described (Fazal et al., 1995).
under fluorescence illumination. At least 200 cells were counted perMacrophages were infected with BCG at a ratio of 5:1, unless other-
coverslip from triplicate cell cultures at 3160±3400 magnification.wise stated.
Monocyte-Derived Macrophage Cultures TUNEL Assay
PBMC were prepared as previously described (Fazal et al., 1995) TUNEL assays were performed on human 7-day cultured MDMs at
and dispensed (2.5 3 106/ml) onto 13-mm plastic Thermonax cov- different times after ATPe treatment. The assays were performed
erslips (Lux Napier) (1 ml/well), within 24-well tissue culture plates using an in situ cell death detection kit (FluoresceinTM, Boehringer
(Costar, Cambridge, MA), (1 ml/well), or into 96 U-well microtitre Mannheim, Lewes, UK). The assays were performed according to
plates (0.2 ml/well) in RPMI-1640 plus 10% AB1 human serum plus the manufacturer's instructions for the quantification of apoptosis
2 mM glutamine (complete medium) and allowed to adhere overnight in adherent cells. Briefly, cell monolayers cultured on 13-mm glass
(16 hr). The coverslips and/or microtitre plates were then washed coverslips (British Drug Houses) were fixed in 4% paraformaldehyde
with warm medium to remove non-adherent cells and incubated solution in PBS, pH 7.4, for 30 min at room temperature. The cov-
at 378C/5%CO2. The cells were activated with rhIFNg (100 U/ml) erslips were then rinsed with PBS and permeabilized by incubation
(Genzyme Ltd., Boston, MA) for 2 days before infection overnight in a 0.1% solution of Triton X-100 in 0.1% sodium citrate for 2 min
(16 hr) with opsonized BCG at an infection ratio of five bacteria per on ice (48C). The coverslips were then rinsed twice with PBS, blotted
cell. The extracellular bacteria were then removed by washing three dry, and to each was added 50 ml of TUNEL reaction mixture (from
times with warm medium. the Boehringer Mannheim kit). The coverslips were incubated in a
humidified chamber for 60 min at 378C in the dark. The coverslips
were rinsed three times with PBS, blotted dry, placed on glassCytotoxicity Assays (51Cr Release)
Six-day-old cultured human macrophage monolayers were labeled slides, and an antifade (ImmunomountR, Shandon Scientific, Ltd.)
was added. The coverslips were then immediately analyzed underwith sodium 51[Cr] chromate (ICN Biomedicals, Irvine, CA) at 2 mCi/
well for 16 hr, as previously described(Fazal et al., 1995). The labeled a fluorescence microscope (3400 magnification), and the numbers
of TUNEL-positive cells per field were quantified. Controls were ascells were washed three times in warm medium to remove excess
51Cr, and then ATP was added for a 30-min pulse. The ATP was follows. Positive control, fixed and permeabilized cells incubated
with DNase I (1 mg/ml for 10 min, room temperature) to inducethen removed and replaced with an equal volume of fresh medium,
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strand breaks; negative control, fixed and permeabilized cells incu- El-Moatassim, C., and Dubyak, G. (1993). Dissociation of the pore-
forming and phospholipase D activities stimulated via P2Z pu-bated with Label Solution (without terminal transferase) instead of
TUNEL reaction mixture; nontreated control, cells processed as for rinergic receptors in BAC1.2F5 macrophages. J. Biol. Chem. 268,
15571±15578.test cultures but not treated with ATPe.
Falazoni, S., Munerati, M., Ferrari, D., Spisani, S., Moretti, S., and
CGD Patients Di Virgilio, F. (1995). The purinergic P2Z receptor of human macro-
CGD was diagnosed in three patients used as cell donors in these phage cells. J. Clin. Invest. 95, 1207±1216.
studies by the Regional Department of Immunology, Heartlands Fazal et al. (1995). Lysis of human macrophages by cytolytic CD41
Hospital on the basis of a negative nitroblue-tetrazolium test (Segal, T cells fails to affect survival of intracellular Mycobacterium bovis-
1974). The x-linked patient had two other male siblings who were bacille Calmette-Guerin (BCG). Clin. Exp. Immunol. 99, 82±89.
affected, and the mother was identified as a carrier. The AR patients
Ferrari, D., Chiozzi, P., Hanau, S., and Di Virgilio, F. (1997). Purinergic(AR 1 and AR 2), both male, had no other affected family members
modulation of interlukin-1B release from microglial cells stimulatedand were diagnosed by R. A. Thompson and genotyped by A. R.
with bacterial endotoxin. J. Exp. Med. 185, 579±582.Segal's laboratory (Department of Medicine, University College,
Filippini, A., Taffs, R.E., Agui, T., and Sitkowsky, M.V. (1990). Ecto-London, UK).
ATPase activity incytolytic T-lymphocytes. Protection from the cyto-
lytic effects of extracellular ATP. J. Biol. Chem. 265, 334±340.Statistics
The Student's t-test was used for all statistical comparisons. Fredholm, B.B., Abbracchio, M.P., Burnstock, G., Daly, J.W.,
Harden, T. K., Jacobson, K.A., Leff, P., and Williams, M. (1994).
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